GUELPH, ON, April 20, 2026 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three- and twelve-month periods ended December 31, 2025 including a $65.3 million order backlog. Biorem's complete fiscal 2025 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Biorem Reports $65.3 Million Order Backlog
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
